ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 135758 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 135758; 2) Community: the network communities that were significantly associated with the response to NSC 135758; 3) Molecule: the relationships between components within communities and NSC 135758; 4) MDR: the compounds that were significantly associated with the NSC 135758.

NSC Compound Enrichment Correlation
NSC 674182 Null 0.0285477013888569 0.70558516
NSC 674268 Null 0.0285477013888569 0.25399372
NSC 679006 2-Butenedioic acid, 2,2'-(5-methyl-2,4-dioxopyrimidine- 1,3-diyl)bis-, tetraethyl ester 0.0285477013888569 0.19176008
NSC 681641 Camptothecin Derivative 0.0285477013888569 0.75599237
NSC 683556 Camptothecin Derivative 0.0285477013888569 0.75795841
NSC 700363 Liposomal Annamycin 0.0285477013888569 0.69307631
NSC 713759 Null 0.0285477013888569 0.22817878
NSC 715974 Null 0.0285477013888569 0.22932939
NSC 726365 Null 0.0285477013888569 0.073828888
NSC 727729 1, 1'[Pentane-1,5-diyl)dioxy]bis(11as)-2-fluoro-7-methoxy-1,2,3 ,11a-tetrahydro-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one 0.0285477013888569 0.67313456
Total:49  Current:31    [First] [Prev] [Next] [Last]